Pharma Journalist -

The FDA has been added to the agenda for Smithers' 9th Extractables and Leachables USA Conference, taking place in Bethesda, MD, April 20-22, 2020. Alan Hood, Research Toxicologist…
Read More...

Novavax, Inc. a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the Coalition for Epidemic Preparedness Innovations…
Read More...

SMi Reports: There will be a workshop surrounding ‘Developing apps for Connected Drug Delivery’ for Injectable Drug Delivery 2020 The Injectable Drug Delivery conference will…
Read More...

COVID-19 Therapeutics Accelerator will coordinate R&D efforts and remove barriers to drug development and scale-up to address the epidemic The Bill & Melinda Gates…
Read More...

Today, AnaBios announced a Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA) to study adult human primary cardiomyocytes as a reference for…
Read More...

Zydus Cadila, an innovation-driven global pharmaceutical company, and XOMA Corporation announced they have entered into a licensing agreement to advance an IL-2-based immuno-oncology…
Read More...

Nanoform, an innovative nanoparticle medicine enabling company, and Orion Corporation, a Finnish pharmaceutical company, announced a collaboration to apply Nanoform's award-winning CESS…
Read More...

ViiV Healthcare and the University of North Carolina at Chapel Hill announced a five-year, $20 million renewal of a unique, public-private research partnership solely focused on…
Read More...

AbbVie confirmed the company's activities in the fight to address the COVID-19 public health crisis, including supporting the experimental use of the HIV medicine, Kaletra/Aluvia…
Read More...

CEL-SCI Corporation announces that it is developing an immunotherapy with the potential to treat the COVID-19 coronavirus using its patented LEAPS peptide technology. The LEAPS peptides…
Read More...